Investigating how a specific protein affects metastatic prostate cancer
Determine the Role of Histone Methyltransferase ASH1L in Metastatic Prostate Cancer
This study is looking at a protein called ASH1L to see how it affects the spread of metastatic prostate cancer, with the hope of finding new ways to treat patients facing this challenge.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10879288 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of the ASH1L protein in the progression of metastatic prostate cancer. By examining how ASH1L influences the tumor immune microenvironment, the study aims to uncover new mechanisms that contribute to cancer spread. Using advanced techniques like genetically engineered mouse models and single-cell transcriptomics, researchers will explore how ASH1L may serve as a potential therapeutic target. This could lead to the development of more effective treatments for patients with metastatic disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with metastatic prostate cancer who may benefit from novel therapeutic approaches.
Not a fit: Patients with localized prostate cancer or those who have not developed metastatic disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that specifically target the mechanisms of metastasis in prostate cancer.
How similar studies have performed: Previous research has shown promising results in targeting epigenetic factors in cancer, suggesting that this approach may yield significant insights and advancements.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Zhao, Di — University of Tx Md Anderson Can Ctr
- Study coordinator: Zhao, Di
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.